03905nam 22006853u 450 99633909140331620230617001213.01-280-30995-497866103099551-84692-543-6(CKB)1000000000463452(EBL)362704(OCoLC)437229078(SSID)ssj0000258331(PQKBManifestationID)12078600(PQKBTitleCode)TC0000258331(PQKBWorkID)10256451(PQKB)10149255(MiAaPQ)55150(EXLCZ)99100000000046345220130418d2005|||| u|| |engur|n|---|||||txtccrTherapeutic Strategies in Thrombosis[electronic resource]Oxford Atlas Medical Publishing Ltd20051 online resource (405 p.)Therapeutic StrategiesDescription based upon print version of record.1-904392-34-2 Contents; Contributors; 1. Arterial thrombosis: a brief overview; 2. Aspirin: a risk-based strategy; 3. Clopidogrel and other platelet ADP inhibitors; 4. Glycoprotein IIb/IIIa inhibitors; 5. Unfractionated heparin and low-molecular-weight heparin in coronary heart disease; 6. Intravenous direct thrombin inhibition: acute coronary syndromes and heparin-induced thrombocytopaenia; 7. Direct thrombin inhibition during percutaneous coronary interventions; 8. Pentasaccharide and other factor Xa inhibitors9. Direct thrombin inhibition - thromboprophylaxis, deep venous thrombosis, atrial fibrillation and coronary artery disease10. Warfarin after acute myocardial infarction; 11. Thrombolytic therapy and concomitantantithrombotic therapy; 12. Pre-hospital reperfusion therapy; 13. Antithrombotic strategies in patients undergoing primary percutaneous intervention; 14. Antithrombotic management in patients with prosthetic valves; 15. Stroke: thrombolysis and antithrombotic therapy; 16. Atrial fibrillation: antithrombotic therapy; 17, Venous thromboembolism: pathophysiology and diagnosis18. Antithrombotic therapy in venous thrombosis and pulmonary embolism19.Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy and renal diseases; 20. Monitoring of antithrombotic drugs; IndexIn this new volume, leading authorities from around the world provide an evidence-based review of the therapeutic options currently available for the management of thrombosis. Topics covered include the use of aspirin for primary and secondary prophylaxis, platelet inhibitors, glycoprotein IIb and IIa inhibitors, pentasaccharides, warfarin, and other agents. Other sections discuss the implementation of antithrombotic therapy in managing specific clinical conditions such as pulmonary embolism, atrial fibrillation, stroke and diabetes, or as an adjunct to other procedures such as PCI.Therapeutic StrategiesThrombolytic therapyThrombosis -- TreatmentThrombosisCardiovascular DiseasesHILCCMedicineHILCCHealth & Biological SciencesHILCCThrombolytic therapy.Thrombosis -- Treatment.Thrombosis.Cardiovascular DiseasesMedicineHealth & Biological Sciences616.13506Kristensen S. D.1955-1019084De Caterina R.1954-602130Moliterno David J893157AU-PeELAU-PeELAU-PeELBOOK996339091403316Therapeutic Strategies in Thrombosis2400581UNISA